首页|我院1800例血小板减少住院患者的临床特征分析

我院1800例血小板减少住院患者的临床特征分析

扫码查看
目的 探讨南方医科大学深圳医院血小板减少住院患者的科室分布及病因,为临床诊疗提供参考.方法 从医院信息管理系统(HIS)中调取1800例血小板减少患者的临床资料,对患者的年龄与性别,病因、科室分布情况,血小板减少的程度进行回顾性分析.结果 1800 例血小板减少患者中位年龄为 56 岁(1 d~98 岁),其中≤60 岁患者 1062 例,占 59.00%;>60 岁患者 738 例,占 41.00%.1800 例患者中男性 993 例,占 55.17%;女性 807 例,占 44.83%.男性患者中位血小板计数为 80×109/L,女性患者中位血小板计数为 80×109/L.1800 例患者中血小板计数≤20×109/L 121 例,占 6.72%;血小板计数(20~50)×109/L 274 例,占 15.22%;血小板计数(51~100)×109/L 1405 例,占 78.06%.1800 例血小板减少患者主要分布在血液科、肝病科、重症医学科、肿瘤科、普通外科等科室,其中血液科占 19.39%,中位血小板计数为 50×109/L.1800 例血小板减少患者中血液系统疾病共 399 例,占比 22.17%;肝脏疾病 346 例,占比 19.22%;肿瘤 300 例,占 16.67%;感染性疾病 297 例,占 16.50%;心脑血管疾病134例,占7.44%;肾病78例,占4.33%;妊娠期血小板减少41例,占2.28%;内分泌疾病27例,占1.50%;其他疾病 178 例,占 9.89%.血液系统疾病平均血小板计数为 50.58×109/L,肝脏疾病平均血小板计数为 72.93×109/L,内分泌疾病平均血小板计数为 74.56×109/L,肿瘤患者平均血小板计数为 75.10×109/L,心脑血管疾病平均血小板计数为 75.73×109/L,肾脏疾病平均血小板计数为 77.01×109/L,感染性疾病平均血小板计数为 78.05×109/L,其他疾病平均血小板计数为 80.65×109/L,妊娠期血小板减少平均血小板计数为 83.10×109/L.其中血液系统疾病患者平均血小板计数最低,且与其余 8 种疾病患者两两比较,差异有统计学意义(P<0.001);肝脏疾病患者平均血小板计数与其他疾病患者比较,差异有统计学意义(P<0.01);其余疾病患者两两比较,差异无统计学意义(P>0.05).结论 2021 年度住院患者血小板减少的主要病因为血液系统疾病、肝病、肿瘤和感染性疾病,其中血液系统疾病患者血小板减少程度最为严重,需要临床重点关注,其他系统疾病引起的血小板减少也需临床高度重视.
Analysis of clinical features of 1800 inpatients with thrombocytopenia in our hospital
Objective To investigate the department distribution and etiology of inpatients with thrombocytopenia in Shenzhen Hospital of Southern Medical University,and to provide reference for clinical diagnosis and treatment.Methods The clinical data of 1800 patients with thrombocytopenia were collected from the hospital information system(HIS),and the age,gender,etiology,department distribution and degree of thrombocytopenia of the patients were analyzed retrospectively.Results The median age of 1800 patients with thrombocytopenia was 56 years old(1 d-98 years old),of which 1062 patients were≤60 years old,accounting for 59.00%;738 patients were>60 year old patients,accounting for 41.00%.Among the 1800 patients,993 cases were males,accounting for 55.17%;807 cases were female,accounting for 44.83%.The median platelet count was 80×109/L in male patients and 80×109/L in female patients.Among 1800 patients,121 cases(6.72%)had platelet count≤20×109/L,274 cases(15.22%)had platelet count(20-50)×109/L;1405 cases(78.06%)had platelet count(51-100)×109/L.1800 patients with thrombocytopenia were mainly distributed in department of hematology,hepatology,intensive care medicine,oncology,general surgery and other departments,among which hematology accounted for 19.39%,and the median platelet count was 50×109/L.There were 399 cases of thrombocytopenia caused by diseases of the blood system,accounting for 22.17%;346 cases of liver disease,accounting for 19.22%;300 cases of tumor,accounting for 16.67%;297 cases of infectious diseases,accounting for 16.50%;134 cases of cardiovascular and cerebrovascular diseases,accounting for 7.44%;78 cases of kidney disease,accounting for 4.33%;41 cases of thrombocytopenia during pregnancy,accounting for 2.28%;27 cases of endocrine diseases,accounting for 1.50%and 178 cases of other diseases,accounting for 9.89%.The mean platelet count for blood system diseases was 50.58×109/L,the mean platelet count for liver diseases was 72.93×109/L,the mean platelet count for endocrine diseases was 74.56×109/L,the mean platelet count for tumor patients was 75.10×109/L,the mean platelet count for cardiovascular and cerebrovascular diseases was 75.73×109/L,the mean platelet count for kidney diseases was 77.01×109/L,the mean platelet count for infectious diseases was 78.05×109/L,and the mean platelet count for other diseases was 80.65×109/L,the mean platelet count for thrombocytopenia during pregnancy was 83.10×109/L.The mean platelet count of patients with blood system diseases was the lowest,and the difference was statistically significant compared with the other 8 diseases(P<0.001).The mean platelet count of patients with liver disease was significantly different from that of patients with other diseases(P<0.01),while there was no statistically statistical significance in pair-to-pair comparison of patients with other diseases(P>0.05).Conclusion The main diseases of inpatients with thrombocytopenia in 2021 are blood system diseases,liver diseases,tumors and infectious diseases.Among them,thrombocytopenia in patients with blood system diseases is the most serious,which needs clinical attention,and thrombocytopenia caused by other system diseases also needs clinical attention.

ThrombocytopeniaInpatientsDepartment distributionEtiology

张德明、黄荣、梁琪、王静、韦唯、李树萍、孙翔、汪洪富、刘欣桐、黄婷婷、周义文

展开 >

518000 南方医科大学深圳医院检验科

血小板减少 住院患者 科室分布 病因

广东省区域联合基金青年基金(2019)国家自然科学基金青年基金(2020)吴阶平医学基金会-临床科研专项资助基金南方医科大学深圳医院"苗苗"培育计划(2018)

2019A151511012082002974320.6750.2021-06-302018MM01

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(1)
  • 8